Evaluation of the success of a therapeutic procedure should be related to the technical and clinical goals set for that procedure. For percutaneous transluminal coronary angioplasty the goal set depends on the clinical circumstances. For stable angina pectoris it is the elimination of exertional ischaemia; however in an elderly patient or a patient with severe associated non-cardiac disease, in whom coronary artery bypass surgery would be too hazardous, the goal may be limited to reducing the severity of angina pectoris to acceptable levels. There may also be a secondary goal of reducing the risk of subsequent major cardiac events, such as acute myocardial infarctions or improving prognosis. The intention in unstable angina is also to eliminate ischaemia but in some cases prevention of an impending infarction and conversion of the symptoms One difficulty with the 20% reduction definition advocated by Gruentzig and coworkers is that the patient may be left with a residual stenosis of 70-80% and still be classified as a success. Sometimes this may be valid but in many patients residual exertional ischaemia would be expected, or recurrent symptoms associated with "restenosis" may be more likely. On the other hand, using criteria such as a residual stenosis of <40% strictly would result in lower primary success rates and in a significant number of patients the procedure may erroneously be classified as unsuccessful, since in a patient with "subtotal" obstruction (so-called "99%" or "98%" stenosis) and unstable angina, reduction of the stenosis to 60% may result in a definite clinical success.
The term "partial success" may be used to describe such a patient but this term has not really been used to any extent in published reports, presumably because mixtures of degrees of success are more difficult to handle statistically.
The term "partial success" may also relate to patients with multivessel disease in whom success may be achieved in one or more vessels but not in all. In these patients the term success refers to procedural success for the individual patient rather than to technical success of dilatation of an individual lesion. For example, in a patient with occlusion in one vessel and 90% stenosis in another, an attempt at reopening the occluded vessel may be unsuccessful whereas the dilatation of the stenosed vessel may be successful both angiographically and clinically, since in many cases treatment of the "culprit" or "target" lesion can result in clinical success without the need for Bourdillon "complete" revascularisation.l2
Part of the problem of defining primary angiographic success is the inaccuracy inherent in the angiographic measurement of percentage diameter stenosis. This can be particularly difficult when there is intimal dissection. There is considerable interobserver and intraobserver variability in these measurements,'3 and unless they are made blind by an independent observer, with or without computer assisted analysis, it is all too easy for any sort of angiographic improvement to be fitted to the given criteria for angiographic primary 
